Advertisement
Advertisement
INCY
Incyte Genomics Inc
127.62
USDSponsored
+2.87
+2.30%
Sep 17, 16:00 UTC -4
Closed
Pre-Market
126.13
-1.49
-1.17%
INCY Earnings Reports
Positive Surprise Ratio
INCY beat 22 of 42 last estimates.
52%
Next Report
Date of Next Report
Oct 26, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.51B
/-$3.45
Implied change from Q2 26 (Revenue/ EPS)
-10.09%
/-211.65%
Implied change from Q3 25 (Revenue/ EPS)
+10.19%
/-253.33%
Incyte Genomics Inc earnings per share and revenue
On Jul 28, 2026, INCY reported earnings of 3.09 USD per share (EPS) for Q2 26, beating the estimate of 2.14 USD, resulting in a 44.14% surprise. Revenue reached 1.67 billion, compared to an expected 1.50 billion, with a 11.37% difference. The market reacted with a +9.30% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 12 analysts forecast an EPS of -3.45 USD, with revenue projected to reach 1.51 billion USD, implying an decrease of -211.65% EPS, and decrease of -10.09% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Incyte Genomics Inc's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Incyte Genomics Inc reported EPS of $3.09, beating estimates by 44.14%, and revenue of $1.67B, 11.37% above expectations.
How did the market react to Incyte Genomics Inc's Q2 2026 earnings?
The stock price moved up 9.3%, changed from $118.87 before the earnings release to $129.93 the day after.
When is Incyte Genomics Inc expected to report next?
The next earning report is scheduled for Oct 26, 2026.
What are the forecasts for Incyte Genomics Inc's next earnings report?
Based on 12
analysts, Incyte Genomics Inc is expected to report EPS of -$3.45 and revenue of $1.51B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.